glasdegib: Clinical Trials

4 trials of glasdegib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1

Follow glasdegib: new trials by email Literature Review of glasdegib trials Research Report on glasdegib

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Glasdegib, Azacitidine - Acute Myeloid Leukemia, Myelodysplastic Syndrome
Phase 3CompletedPfizer142021-05-172023-12-18
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib - Acute Myeloid Leukemia
Phase 3TerminatedUniversity Hospital Heidelberg282021-04-012022-07-01
Molecular Profiling of Advanced Soft-tissue Sarcomas
Nilotinib, Ceritinib, Capmatinib - Soft Tissue Sarcoma
Phase 3CompletedInstitut National de la Santé Et de la Recherche Médicale, France6032019-10-192026-04-29
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
glasdegib, daunorubicin + cytarabine, azacitidine - Leukemia, Myeloid, Acute
Phase 3CompletedPfizer7302018-04-202023-04-21

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)  ·  Sarcoma (1)

Sponsors

Pfizer (2)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  University Hospital Heidelberg (1)

Countries

France (3)  ·  Austria (2)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Japan (2)  ·  Mexico (2)  ·  Poland (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  China (1)

Top investigators

Antoine Italiano (1)

Results publications

PMID 31516032, PMID 32713836, PMID 34732236, PMID 34740331, PMID 37604981

NIH funding

2017 (3)